Cimzia Rheumatoid Arthritis Approval Held Up By Safety Request
This article was originally published in The Pink Sheet Daily
Executive Summary
UCB receives “complete response” letter from FDA on second indication for the biologic, approved for Crohn’s disease with a REMS.